Page last updated: 2024-09-03

1-propylxanthine and 1,3-dipropyl-8-cyclopentylxanthine

1-propylxanthine has been researched along with 1,3-dipropyl-8-cyclopentylxanthine in 1 studies

Compound Research Comparison

Studies
(1-propylxanthine)
Trials
(1-propylxanthine)
Recent Studies (post-2010)
(1-propylxanthine)
Studies
(1,3-dipropyl-8-cyclopentylxanthine)
Trials
(1,3-dipropyl-8-cyclopentylxanthine)
Recent Studies (post-2010) (1,3-dipropyl-8-cyclopentylxanthine)
6011,3011165

Protein Interaction Comparison

ProteinTaxonomy1-propylxanthine (IC50)1,3-dipropyl-8-cyclopentylxanthine (IC50)
Adenosine receptor A1Rattus norvegicus (Norway rat)0.0051
Adenosine receptor A3Rattus norvegicus (Norway rat)0.0038
Adenosine receptor A2aHomo sapiens (human)0.2033
Adenosine receptor A2bHomo sapiens (human)0.0234
Adenosine receptor A1Homo sapiens (human)0.0083

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's1 (100.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Jacobson, KA; Kim, HS; Kim, SA; Linden, J; Marshall, MA; Melman, N; Müller, CE1

Other Studies

1 other study(ies) available for 1-propylxanthine and 1,3-dipropyl-8-cyclopentylxanthine

ArticleYear
Structure-activity relationships at human and rat A2B adenosine receptors of xanthine derivatives substituted at the 1-, 3-, 7-, and 8-positions.
    Journal of medicinal chemistry, 2002, May-23, Volume: 45, Issue:11

    Topics: Animals; Binding, Competitive; Cell Line; Cloning, Molecular; Humans; Ligands; Purinergic P1 Receptor Antagonists; Radioligand Assay; Rats; Rats, Sprague-Dawley; Receptor, Adenosine A2B; Receptors, Purinergic P1; Recombinant Proteins; Structure-Activity Relationship; Xanthines

2002